Sector Chart Tenax Therapeutics, Inc.

Stocks

TENX

US88032L6056

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 12:58:35 2026-09-08 EDT			5-day change	1st Jan Change
2.015 ^USD	+3.87%		+13.06%	-83.31%

08-31	Guggenheim Downgrades Tenax Therapeutics to Neutral From Buy	MT
08-29	Tenax Therapeutics Presents Additional Results from Phase 3 Level Clinical Trial Evaluating Tnx-103 in Patients with Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
TENAX THERAPEUTICS, INC.	111M	-	-	-	-	-
LONZA GROUP AG	48.41B
REVOLUTION MEDICINES, INC.	45.01B	-	-	-	-	-
IQVIA HOLDINGS INC.	44.07B
BEONE MEDICINES AG	40.73B
CELLTRION, INC.	33.21B